Published time: 03 May 2020
Authors: Ali FETTAH , Zeynep KARAKAŞ
Keywords: COVID-19, thalassemia, sickle cell disease
The novel coronavirus disease (COVID-19) was firstly reported at the end of 2019. The disease rapidly spread all around the world in a few months and was declared a worldwide pandemic by the World Health Organisation in March 2020. COVID-19 causes respiratory tract illness that may generally occur as mild upper respiratory tract disease or pneumonia. Older patients and those with pre-existing medical conditions such as hypertension, diabetes, cardiovascular disease, cancer, chronic lung disease, and chronic kidney disease have been identified as populations at risk of a severe disease course. Therefore, it is not clear how COVID-19 will progress in hemoglobinopathies such as sickle cell anemia and thalassemia, which are common comorbidity. In this review, it is planned to examine the condition of COVID-19, in which we still have limited information and remains unknown, in sickle cell anemia and thalassemia patients.
COVID-19 ve Hemoglobinopatiler